Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers

Schizophr Res. 2010 Jun;119(1-3):269-70. doi: 10.1016/j.schres.2010.02.1064. Epub 2010 Mar 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzazepines / pharmacology*
  • Cotinine / blood
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases / genetics*
  • Gene Expression / drug effects*
  • Humans
  • Nicotine / blood
  • Nicotinic Agonists / pharmacology*
  • Quinoxalines / pharmacology*
  • RNA, Messenger / genetics*
  • Schizophrenia / blood
  • Schizophrenia / genetics*
  • Smoking Cessation*
  • Varenicline

Substances

  • Benzazepines
  • Nicotinic Agonists
  • Quinoxalines
  • RNA, Messenger
  • Nicotine
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases
  • DNMT1 protein, human
  • Cotinine
  • Varenicline